title: Effects of high dose IV pamidronate on disease activity and bone metabolism in patients with active RA: a randomized, double-blind, placebo-controlled trial.
authors.forename: Mariette C
authors.initials: MC
authors.lastname: Lodder
authors.forename: Philomine A
authors.initials: PA
authors.lastname: Van Pelt
authors.forename: Willem F
authors.initials: WF
authors.lastname: Lems
authors.forename: Piet J
authors.initials: PJ
authors.lastname: Kostense
authors.forename: Cees H W
authors.initials: CH
authors.lastname: Koks
authors.forename: Ben A C
authors.initials: BA
authors.lastname: Dijkmans
mesh_terms: D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001172:Arthritis, Rheumatoid / Q000175:diagnosis* / Q000188:drug therapy*; D001842:Bone and Bones / Q000187:drug effects* / Q000378:metabolism*; D004164:Diphosphonates / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D000077268:Pamidronate; D012016:Reference Values; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D004164:Diphosphonates; D000077268:Pamidronate